Prof.
Yossi
Tam
Area of Interest:
Endocannabinoids, Cannabinoid-1 (CB1) receptor,peripheral CB1 receptor blockade, diet-induced obesity,diabetes, metabolic syndrome, leptin resistance, diabetic nephropathy, renal function, syndromic obesity, Prader- Willi Syndrome, fatty liver (Hepatic Steatosis), nonalcoholic fatty liver disease (NAFLD), hepatic SIRT1and PPAR-alpha signaling, insulin resistance, metabolism
Endocannabinoids, Cannabinoid-1 (CB1) receptor,peripheral CB1 receptor blockade, diet-induced obesity,diabetes, metabolic syndrome, leptin resistance, diabetic nephropathy, renal function, syndromic obesity, Prader- Willi Syndrome, fatty liver (Hepatic Steatosis), nonalcoholic fatty liver disease (NAFLD), hepatic SIRT1and PPAR-alpha signaling, insulin resistance, metabolism